Company Financials

Harmony Biosciences Holdings, Inc. Financials

United States dollar

business Harmony Biosciences Holdings, Inc. Company Profile

Main Stock Listing

NASDAQ: HRMY

Market Capitalization $2.15 Billion as of Jan. 1, 2026

Market Cap History

Valuations Metrics as of Jan. 3, 2026

Trailing PE 11.79
Forward PE 6.66
Price to Sales TTM $2.61
Price to Book MRQ $2.58
Enterprise to Revenue 2.00
Enterprise to EBITDA 6.61

Financial Reports as of Sep. 30, 2025

Financials

Fiscal Year Ends 2024-12-31
Most Recent Quarter 2025-09-30
Profit Margin 22.48%
Operating Margin 27.35%
Return on Assets TTM 13.20%
Return on Equity TTM 25.93%

Income Statement

Revenue TTM $825,944,000
Revenue per Share TTM $14.36
Quarterly Revenue Growth 28.70%
Gross Profit TTM $641,737,984
EBITDA $269,642,000
Net Income to Common TTM $185,676,000
Diluted EPS TTM $3.17
Quarterly Earnings Growth YoY 10.40%

Balance Sheet

Total Cash MRQ $672,580,992
Total Cash per Share MRQ $11.68
Total Debt MRQ $
Total Debt to Equity MRQ 20.32
Current Ratio MRQ 3.76
Book Value per Share MRQ $14.50

Cash Flow

Operating Cash Flow TTM $297,609,984
Levered Free Cash Flow TTM $187,588,368

HRMY Stock Info as of Jan. 3, 2026

Stock Statistics

Shares Outstanding 57,596,358
Float Shares 50,705,530
Avg 10 Volume 559,430
Avg 30 Volume None
Shares Short 4,342,807
Short Ratio 5.32
Short % of Shares 16.48%
% Held by Insiders 12.15%
% Held by Institutions 88.40%

Stock Price Summary

Beta 0.80
Fifty Two Week Low $25.52
Fifty Two Week High $40.93
Fifty Two Week Change 7.71%
Day 50 MA $34.87
Day 200 MA $33.23

Dividends and Splits

Forward Annual Dividend Rate $
Forward Annual Dividend Yield %
Trailing Annual Dividend Rate $0.00
Trailing Annual Dividend Yield 0.00%
Payout Ratio 0.00%
Dividend Date
Ex Dividend Date
Last Split Factor
Last Split Date